Statistics on the burden of dementia: need for stronger data

www.thelancet.com/neurology Vol 18 January 2019 25 attributable to SCI is difficult to appreciate fully. The consequences of an AIS grade A (ie, complete) SCI, for example, are very different from those of an AIS grade D injury. With additional data from large regional, national, and international registries of patients with SCI, we hope that future iterations of this study will be appropriately positioned to provide more accurate and granular estimates of the burden of SCI. All in all, the GBD 2016 TBI and SCI Collaborators’ study is a formidable undertaking and the authors are to be congratulated for this important contribution to the literature. This study serves as a sobering reminder that, despite improvements in access to, and quality of, trauma care, the effects of neurotrauma continue to loom large on a global scale. We hope, however, that, by illuminating the ongoing and profound effects of TBI and SCI internationally, studies such as this one will inspire and invigorate clinicians, researchers, and policy makers to redouble efforts to develop improved prevention and treatment strategies.

[1]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[2]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[3]  L. Launer Counting dementia: There is no one “best” way , 2011, Alzheimer's & Dementia.

[4]  S. Zehetmayer,et al.  Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.

[5]  M. Schumacher,et al.  Incidence of Dementia over Three Decades in the Framingham Heart Study. , 2016, The New England journal of medicine.

[6]  Carole Dufouil,et al.  Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study. , 2018, The Lancet. Public health.

[7]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[8]  M. Schumacher,et al.  A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining? , 2019, European Journal of Epidemiology.

[9]  Nancy Argüelles,et al.  Author ' s , 2008 .

[10]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[11]  T. Montine,et al.  Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies , 2016, Neurology.

[12]  Carole Dufouil,et al.  Guidelines for reporting methodological challenges and evaluating potential bias in dementia research , 2015, Alzheimer's & Dementia.